BONE LOSS IN CORTICOSTEROID TREATED PATIENTS WITH HBSAG NEGATIVE CHRONIC ACTIVE HEPATITIS (CAH)

被引:0
|
作者
STELLON, AJ [1 ]
DAVIES, A [1 ]
WILLIAMS, RS [1 ]
机构
[1] UNIV LONDON KINGS COLL HOSP,LIVER UNIT,LONDON SE5 8RX,ENGLAND
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A558 / A559
页数:2
相关论文
共 50 条
  • [41] CHRONIC ACTIVE HEPATITIS (CAH) - CRITERIA FOR TREATMENT
    ASCIONE, A
    LINARDI, C
    DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (12) : 1144 - 1145
  • [42] DETECTION OF NOVEL ANTIBODIES TO HEPATITIS C VIRUS IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS (CAH)
    TIBBS, CJ
    GLAZEBROOKE, J
    RODGERS, B
    PHIPPARD, D
    HIGHFIELD, P
    SMITH, H
    ALEXANDER, GJM
    EDDLESTON, ALWF
    WILLIAMS, R
    GUT, 1990, 31 (10) : A1210 - A1210
  • [43] DIFFERENCES IN THE DEVELOPMENT OF HBSAG-POSITIVE AND HBSAG-NEGATIVE FORMS OF CHRONIC ACTIVE HEPATITIS
    DZHALALOVA, VA
    DROZD, TN
    BEKETOVA, TP
    SKRYABINA, EG
    KLINICHESKAYA MEDITSINA, 1986, 64 (11): : 73 - 78
  • [44] LOW-DOSE CORTICOSTEROID-THERAPY AFTER MULTIPLE RELAPSES OF SEVERE HBSAG-NEGATIVE CHRONIC ACTIVE HEPATITIS
    CZAJA, AJ
    HEPATOLOGY, 1990, 11 (06) : 1044 - 1049
  • [45] PERIPORTAL NECROSIS IN STEROID-TREATED CHRONIC ACTIVE HEPATITIS (CAH) - A BENIGN LESION
    DAVIS, GL
    CZAJA, AJ
    GASTROENTEROLOGY, 1981, 80 (05) : 1132 - 1132
  • [46] HBsAg Kinetics Prior to HBsAg Loss after Cessation of Entecavir Therapy in Hbeag-Negative Chronic Hepatitis B Patients
    Jeng, Wen-Juei
    Chang, Ming-Ling
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 : 272A - 272A
  • [47] Changes of serum HBsAg levels in HBeAg-negative chronic hepatitis B patients treated with tenofovir
    Papatheodoridis, George V.
    Triantos, Christos K.
    Hadziyannis, Emilia
    Zisimopoulos, Konstantinos
    Georgiou, Anastasia
    Margariti, Katerina
    Deutsch, Melanie
    Nikolopoulou, Vasiliki
    Manolakopoulos, Spilios
    HEPATOLOGY, 2013, 58 : 686A - 687A
  • [48] HBsAg clearance in HBeAg negative infection and treated chronic hepatitis B is associated with different HBsAg kinetics
    Colombatto, P.
    Bleve, P.
    Oliveri, F.
    Cavallone, D.
    Ricco, G.
    Coco, B.
    Romagnoli, V.
    Salvati, A.
    Bonino, F.
    Brunetto, M. R.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E27 - E28
  • [49] LYMPHOCYTE CYTOTOXICITY TO AUTOLOGOUS HEPATOCYTES IN HBSAG-NEGATIVE CHRONIC ACTIVE HEPATITIS
    VERGANI, GM
    VERGANI, D
    JENKINS, PJ
    PORTMANN, B
    MOWAT, AP
    EDDLESTON, ALWF
    WILLIAMS, R
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1979, 38 (01): : 16 - 21
  • [50] Improvement of HBsAg Loss by additional PEG IFN in Nucleosides Analogs treated Chronic Hepatitis B Patients
    Wu, Zhongwen
    Sheng, Jifang
    Li, Lanjuan
    HEPATOLOGY, 2012, 56 : 404A - 404A